Skip to main content
. 2015 Mar 6;123(7):730–736. doi: 10.1289/ehp.1308005

Table 1.

Characteristics of the cohorts [median (range) or n (%)].

Characteristic Duisburg(Germany,2000–2002)(n = 222) ELFE (France,2007)(n = 35) FLEHS I(Belgium,2002–2004)(n = 134) GRD(Germany, Netherlands,1990–1995)(n = 588) HUMIS(Norway,2002–2006) (n = 399) Michalovce(Slovakia,2002–2004)(n = 938) PELAGIE(France,2002–2006)(n = 171)
Change in weight-for-age z-score 0–24 months –0.13 (–2.74–4.83) 0.06 (–2.38–2.21) 0.04 (–2.59–3.40) –0.03 (–3.87–3.46) –0.03 (–3.91–3.83) –0.01 (–5.01–3.72) 0.03 (–2.85–3.63)
Missing (%) 0 0 0 0 1 3 0
Weight 24 m (kg) 13.56 (10.35–17.50) 12.00 (9.93–13.47) 12.53 (10.01–15.87) 13.21 (9.89–18.54) 12.19 (8.36–18.49) 13.66 (10.08–20.26) 12.39 (8.86–16.78)
Missing (%) 0 0 0 0 1 2 0
Height 24 m (cm) 87.4 (76.6–95.8) 87.6 (82.9–104.7) 88.0 (77.7–94.4) 88.6 (80.5–98.1) 86.3 (71.2–108.3) 86.2 (74.9–96.3) 87.5 (78.8––96.3)
Missing (%) 0 0 0 0 1 2 0
Birth weight (g) 3.460 (1.960–4.925) 3.340 (2.800–4.110) 3.383 (2.600–4.530) 3.500 (2.140–5.000) 3.680 (2.030–5.100) 3.370 (2.060–5.060) 3.370 (2.320–4.760)
Missing (%) 0 0 0 0 0 3 0
Birth length (cm) 52 (42–61) 49 (47–52) 50.7 (48.2–53.1) 52.5 (44–60) 51 (42–55) 50 (40–57) 50 (43–55)
Missing (%) 0 0 0 0 10 22 0
Gestational age (weeks) 40 (37–42) 40 (38–41) 40 (37–41) 40 (37–43) 40 (37–44) 40 (37–43) 40 (37–42)
Missing (%) 1 0 0 0 5 10 0
Sex
Male 108 (48.7) 18 (51.4) 72 (53.7) 322 (54.8) 203 (51.1) 477 (51.0) 92 (53.8)
Female 114 (51.4) 17 (48.6) 62 (46.3) 266 (45.2) 195 (49.0) 459 (49.0) 79 (46.2)
Missing (%) 0 0 0 0 1 2 0
Maternal age (years) 31.9 (19.3–42.6) 32.9 (24.3–41.3) 31.1 (20.3–41.1) 29 (18–40) 29 (16–42) 25.7 (17.9–45) 31.1 (20.1–45)
Missing (%) 0 0 0 0 0 11 0
Maternal prepregnancy BMI 23.0 (14.9–51.4) 21.5 (18.1–27.7) 22.4 (16.9–37.4) 22.1 (15.0–48.3) 23.3 (16.6–43.8) 21.2 (14.5–40.7) 21.9 (17.3–37.6)
Missing (%) 0 1 1 1 6 44 0
Maternal prepregnancy weight (kg) 65 (42–140) 58 (47–78) 62 (45–112) 64 (44–133) 66 (43–120) 58 (38–115) 58 (46–105)
Missing (%) 0 0 1 1 4 44 0
Maternal gestational weight gain (kg) NA NA 15.0 (1.0–30.0) NA 14.0 (–3.0–31.0) 14.0 (1.0–35.0) 13.0 (5.0–31.0)
Missing (%) 222 35 60 588 8 250 0
Maternal height (cm) 168 (151–183) 163 (148–173) 168 (150–183) 170 (150–193) 168 (149–199) 165 (133–186) 165 (150–190)
Missing (%) 0 1 1 0 3 0 0
Parity
0 0 (0.0) 12 (34.3) 84 (62.7) 294 (50.0) 154 (38.6) 391 (41.7) 68 (39.8)
≥ 1 222 (100.0) 23 (65.7) 50 (37.3) 294 (50.0) 245 (61.4) 547 (58.3) 103 (60.2)
Missing (%) 0 0 0 0 0 1 0
Education
Low 50 (22.5) 1 (2.9) 5 (3.7) 73 (12.4) 53 (13.4) 177 (19.0) 29 (17.0)
Medium 83 (37.4) 8 (22.9) 96 (73.3) 184 (31.4) 253 (64.1) 687 (73.7) 26 (15.2)
High 89 (40.1) 26 (74.3) 30 (22.9) 330 (56.2) 89 (22.5) 68 (7.3) 116 (67.84)
Missing (%) 0 0 3 1 4 6 0
Maternal smoking during pregnancya
No 169 (76.1) 33 (100.0) 120 (90.2) 438 (74.5) 357 (89.5) 805 (85.8) 137 (80.6)
Yes 53 (23.9) 0 13 (9.8) 150 (25.5) 42 (10.5) 133 (14.2) 33 (19.4)
Missing (%) 0 2 1 0 0 0 1
Ethnicity
Caucasian 211 (95.1) NA NA 588 (100.0) 374 (98.2) 738 (80.7) 171 (100.0)
Inuit 0 NA NA 0 2 (0.5) 0 0
Roma 0 NA NA 0 1 (0.3) 177 (19.3) 0
Other 11 (5.0) NA NA 0 4 (1.1) 0 0
Missing (%) 0 35 134 0 17 23 0
Sample type
Maternal blood 216 0 0 0 0 0 0
Cord blood 0 0 130 267 0 880 168
Breast milk 0 35 0 321 399 0 0
Missing (%) 6 0 4 0 0 58 3
Sample collection time (days from birth) –51 (–107–42) 51 (36–70) 0 (0–0) CB: 0 (0–0) BM: 14 (14–14) 32 (2–158) 0 (0–0) 0 (0–0)
Missing (%) 6 0 4 0 18 58 3
Total breastfeeding (months) 6.9 (0.2–18) 5.0 (1.6–23) 3 (0–48) 2.3 (0–6) 12 (1–31.2) 5 (0–48) 3.1 (0–24.8)
Missing (%) 38 2 42 5 0 5 8
No breastfeeding 0 (0) 0 (0) 34 (25.4) 224 (38.1) 0 (0) 2 (0.2) 70 (40.9)
Missing (%) 38 2 42 5 0 5 8
Exclusive breastfeeding (months) 4.8 (0–9.9) NA 0 (0–1) NA 5 (0–10) 3 (0–12) NA
Missing (%) 39 35 76 588 0 3 171
Abbreviations: BM, breast milk; CB, cord blood; ELFE, Etude Longitudinale Française depuis l’Enfance (French Longitudinal Study of Children); FLEHS I, Flemish Environment and Health Survey I; GRD, Groningen–Rotterdam–Düsseldorf; HUMIS, Human Milk Study; NA, not available; PELAGIE, Endocrine disruptors: longitudinal study on pathologies of pregnancy, infertility and childhood. Continuous measures described by median (minimum–maximum); categorical measures described by frequencies (%).aIn PELAGIE, smoking status at inclusion was used as proxy for smoking during pregnancy.